The effectiveness and safety of pharmacological prophylaxis against venous thromboembolism in patients with moderate to severe traumatic brain injury: A systematic review and meta-analysis

Journal of Trauma and Acute Care Surgery

Volumn 81, Issue 3, 2016, Pages 567-574

  Galan, Luis Albeiro Mesa ^a   Egea Guerrero, Juan José ^b   Diaz, Manuel Quintana ^a   Vilches Arenas, Angel ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Craniocerebral trauma; Intermittent pneumatic compression devices; low molecular weight heparin; pulmonary embolism; venous thromboembolism; venous thrombosis

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT;

CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COMPRESSION THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EMBASE; EMBOLISM PREVENTION; HOSPITAL ADMISSION; HUMAN; MECHANICAL COMPRESSION; MEDLINE; META ANALYSIS; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; TRAUMATIC BRAIN INJURY; VENOUS THROMBOEMBOLISM; COMPLICATION;

ANTICOAGULANTS; BRAIN INJURIES, TRAUMATIC; HUMANS; VENOUS THROMBOEMBOLISM;

EID: 84973137594     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000001134     Document Type: Review

References (27)

1. Kaufman HH, Satterwhite T, McConnell BJ, Costin B, Borit A, Gould L, Pruessner J, Bernstein D, Gildenberg PL. Deep vein thrombosis and pulmonary embolism in head injured patients. Angiology. 1983; 34: 627-638.
2. Knudson MM, Ikossi DG, KhawL, MorabitoD, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004; 240: 490-496; discussion 496-8.
3. Brain Trauma Foundation, AmericanAssociation of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis. J Neurotrauma. 2007; 24(Suppl 1): S32-6.
4. Sadaka F, Belvadi Y, Sheikh M, O'Brien J, Srivastava A, Lakshmanan R. Safety and efficacy of early pharmacologic thromboprophylaxis in traumatic brain injury. Crit Care Med. 2013; 41: A54-A55.
5. Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, Beltrametti C, Damiani M, Andrioli GC, Pugliese R, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998; 339: 80-85.
6. Kurtoglu M, Yanar H, Bilsel Y, Guloglu R, Kizilirmak S, Buyukkurt D, Granit V. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg. 2004; 28: 807-811.
7. Menaker J, Stein DM, Scalea TM. Incidence of early pulmonary embolism after injury. J Trauma. 2007; 63: 620-624.
8. Norwood SH, Berne JD, Rowe SA, Villarreal DH, Ledlie JT. Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury. J Trauma. 2008; 65: 1021-1026.
9. Phelan HA, Eastman AL, Madden CJ, Aldy K, Berne JD, Norwood SH, Scott WW, Bernstein IH, Pruitt J, Butler G, et al. TBI risk stratification at presentation: a prospective study of the incidence and timing of radiographic worsening in the parkland protocol. J Trauma Acute Care Surg. 2012; 73: S122-S127.
10. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009; 62: e1-e3.
11. Sterne JAC, Higgins JPT, Reeves BC; on behalf of the development group for ACROBATNRSI. A Cochrane Risk Of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBATNRSI), Version 1.0. 0, 24 September 2014. Available at: http://www.riskofbias.info
12. Koehler DM, Shipman J, Davidson MA, Guillamondegui O. Is early venous thromboembolism prophylaxis safe in trauma patients with intracranial hemorrhage. J Trauma. 2011; 70: 324-329.
13. Scudday T, Brasel K, Webb T, Codner P, Somberg L, Weigelt J, Herrmann D, Peppard W. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J Am Coll Surg. 2011; 213: 148-153.
14. Minshall CT, Eriksson EA, Leon SM, DobenAR, McKinzie BP, Fakhry SM. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score 2. J Trauma. 2011; 71: 396-400.
15. Salottolo K, Offner P, Levy AS, Mains CW, Slone DS, Bar-Or D. Interrupted pharmocologic thromboprophylaxis increases venous thromboembolism in traumatic brain injury. J Trauma. 2011; 70: 19-26.
16. Levy AS, Salottolo K, Bar-Or R, Offner P, Mains C, Sullivan M, Bar-Or D. Pharmacologic thromboprophylaxis is a risk factor for hemorrhage progression in a subset of patients with traumatic brain injury. J Trauma. 2010; 68: 886-892.
17. Kwiatt ME, Patel MS, Ross SE, Lachant MT, MacNew HG, Ochsner MG, Norwood SH, Speier L, Kozar R, Gerber JA, et al. Is low-molecularweight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury?. A Western trauma association multicenter study. J Trauma Acute Care Surg. 2012; 73: 625-628.
18. Depew AJ, Hu CK, Nguyen AC, Driessen N. Thromboembolic prophylaxis in blunt traumatic intracranial hemorrhage: a retrospective review. Am Surg. 2008; 74: 906-911.
19. Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G, Rue LW. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009; 66: 1436-1440.
20. Kim KS, Brophy GM. Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit Care. 2009; 11: 28-33.
21. Farooqui A, Hiser B, Barnes SL, Litofsky NS. Safety and efficacy of early thromboembolism chemoprophylaxis after intracranial hemorrhage from traumatic brain injury: clinical article. J Neurosurg. 2013; 119: 1576-1582.
22. Nickele CM, Kamps TK, Medow JE. Safety of a DVT chemoprophylaxis protocol following traumatic brain injury: a single center quality improvement initiative. Neurocrit Care. 2013; 18: 184-192.
23. Lin M, Davis JV, Wong DT. Evaluation of heparin prophylaxis protocol on deep venous thrombosis and pulmonary embolism in traumatic brain injury. Am Surg. 2013; 79: 1050-1053.
24. Saadeh Y, Gohil K, Bill C, Smith C, Morrison C, Mosher B, Schneider P, Stevens P, Kepros JP. Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT. J Trauma Acute Care Surg. 2012; 73: 426-430.
25. Norwood SH, McAuley CE, Berne JD, Vallina VL, Kerns DB, Grahm TW, Short K, McLarty JW. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002; 137: 696-701; discussion 701-2.
26. Jamjoom AA, Jamjoom AB. Safety and efficacy of early pharmacological thromboprophylaxis in traumatic brain injury: systematic review and metaanalysis. J Neurotrauma. 2013; 30: 503-511.
27. Phelan HA, Wolf SE, Norwood SH, Aldy K, Brakenridge SC, Eastman AL, Madden CJ, Nakonezny PA, Yang L, Chason DP, et al. A randomized, double-blinded, placebo-controlled pilot trial of anticoagulation in low-risk traumatic brain injury: The delayed versus early enoxaparin prophylaxis i (DEEP I) study. J Trauma Acute Care Surg. 2012; 73: 1434-1441.